SEC Form 3 · accession 0001209191-19-005052
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian Woolfson
Officer — EVP, Research and Development
Period of report
Jan 21, 2019
Accepted (ET)
Jan 23, 2019 · 7:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 18,679 | D |
Table II — derivative securities
No Table II lines on this filing.